We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Amicus Therapeutics has received the US Food and Drug Administration (FDA) approval for its Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat) 65mg capsules to treat late-onset Pompe disease (LOPD).
American biotech company Scynexis has issued a voluntary nationwide recall of two lots of Brexafemme (ibrexafungerp tablets) to the consumer level in the US market due to the
Fabre-Kramer Pharmaceuticals has received the US Food and Drug Administration (FDA) approval for Exxua (gepirone hydrochloride extended-release tablets) to treat major depressive disorder (MDD) in adults. Exxua is
Merck, known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review a new
Maryland-based biotech company Deka Biosciences today announced that it has successfully closed a USD $20 Million Series B2 financing with a syndicate of life science investors led by
US-based Viatris and Ocuphire Pharma have received US Food and Drug Administration (FDA) approval for Ryzumvi (phentolamine ophthalmic solution) 0.75% eye drops to treat pharmacologically induced mydriasis produced
American biotech company Ginkgo Bioworks has announced a collaboration agreement with Pfizer to discover and develop new RNA molecules across priority research areas. Under the partnership, Pfizer will
Deep Genomics, an artificial intelligence (AI) drug development firm, has launched BigRNA, an AI foundation model for RNA disease mechanisms and discovery of candidate therapeutics. BigRNA is a
Takeda today announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) administration of ENTYVIO (vedolizumab) for maintenance therapy in adults with moderately to
Evozyne announced the closing of an $81 million Series B investment round that will fund the biotech’s generative AI-powered drug discovery platform and product development. Fidelity Management &